BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Rating) is set to release its earnings data before the market opens on Thursday, May 5th. Analysts expect BioCryst Pharmaceuticals to post earnings of ($0.39) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.
BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Rating) last released its quarterly earnings results on Wednesday, February 23rd. The biotechnology company reported ($0.40) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.
